好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Intravenous Administration of the Serotonin (5HT) [sub]1B/D[/sub] Receptor Agonist Zolmitriptan Blocks Central Sensitization in the Trigeminal Nucleus Caudalis
001
Authors/Disclosures
Khalil Husari, MD (University of Texas Southwestern Medical Center) The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
No disclosure on file
Peter Sguigna, MD (UT Southwestern Medical Center) Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
No disclosure on file
Ty Shang, MD (UT Southwestern Medical Center) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file